NO302616B1 - N,N'-substituerte imidokarbonimiddiaminer avledet fra hydroksylaminer - Google Patents

N,N'-substituerte imidokarbonimiddiaminer avledet fra hydroksylaminer

Info

Publication number
NO302616B1
NO302616B1 NO942988A NO942988A NO302616B1 NO 302616 B1 NO302616 B1 NO 302616B1 NO 942988 A NO942988 A NO 942988A NO 942988 A NO942988 A NO 942988A NO 302616 B1 NO302616 B1 NO 302616B1
Authority
NO
Norway
Prior art keywords
group
carbon atoms
mono
substituted
salts
Prior art date
Application number
NO942988A
Other languages
English (en)
Norwegian (no)
Other versions
NO942988L (no
NO942988D0 (no
Inventor
Craig Canfield
David Jacobus
Neil Lewis
Original Assignee
Jacobus Pharma Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jacobus Pharma Co Inc filed Critical Jacobus Pharma Co Inc
Publication of NO942988D0 publication Critical patent/NO942988D0/no
Publication of NO942988L publication Critical patent/NO942988L/no
Publication of NO302616B1 publication Critical patent/NO302616B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C279/20—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups containing any of the groups, X being a hetero atom, Y being any atom, e.g. acylguanidines
    • C07C279/24—Y being a hetero atom
    • C07C279/26—X and Y being nitrogen atoms, i.e. biguanides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06—Antimalarials
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/10—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C323/11—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and singly-bound oxygen atoms bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C323/13—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and singly-bound oxygen atoms bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being saturated and containing rings
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Detergent Compositions (AREA)
  • Paints Or Removers (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Luminescent Compositions (AREA)
  • Seasonings (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Peptides Or Proteins (AREA)
NO942988A 1992-02-14 1994-08-12 N,N'-substituerte imidokarbonimiddiaminer avledet fra hydroksylaminer NO302616B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/837,258 US5322858A (en) 1992-02-14 1992-02-14 N,N'-substituted imidodicarbonimidic diamides derived from hydroxylamines
PCT/US1993/000395 WO1993016037A1 (en) 1992-02-14 1993-01-19 N,n'-substituted imidocarbonimidic diamides derived from hydroxylamines

Publications (3)

Publication Number Publication Date
NO942988D0 NO942988D0 (no) 1994-08-12
NO942988L NO942988L (no) 1994-10-05
NO302616B1 true NO302616B1 (no) 1998-03-30

Family

ID=25273975

Family Applications (1)

Application Number Title Priority Date Filing Date
NO942988A NO302616B1 (no) 1992-02-14 1994-08-12 N,N'-substituerte imidokarbonimiddiaminer avledet fra hydroksylaminer

Country Status (25)

Country Link
US (1) US5322858A (ja)
EP (1) EP0625967B1 (ja)
JP (1) JP3207200B2 (ja)
KR (1) KR950700243A (ja)
CN (1) CN1057520C (ja)
AT (1) ATE157352T1 (ja)
AU (1) AU668709B2 (ja)
CA (1) CA2129430C (ja)
CZ (1) CZ294257B6 (ja)
DE (1) DE69313438T2 (ja)
DK (1) DK0625967T3 (ja)
EG (1) EG20476A (ja)
ES (1) ES2108862T3 (ja)
FI (1) FI943738A (ja)
GR (1) GR3025429T3 (ja)
HU (1) HU220389B (ja)
IL (1) IL104484A (ja)
MX (1) MX9300688A (ja)
NO (1) NO302616B1 (ja)
NZ (1) NZ245865A (ja)
OA (1) OA10094A (ja)
PL (2) PL173258B1 (ja)
RU (1) RU2133737C1 (ja)
WO (1) WO1993016037A1 (ja)
ZA (1) ZA93974B (ja)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4321444A1 (de) * 1993-06-28 1995-01-05 Bernd Prof Dr Clement Pharmazeutische Zubereitung
US6551614B2 (en) 2001-03-14 2003-04-22 Jacobus Pharmaceutical Co., Inc. Antimalarial N,N′-substituted biguanides derived from hydroxylamines
CA2477604A1 (en) 2002-03-13 2003-09-25 Signum Biosciences, Inc. Modulation of protein methylation and phosphoprotein phosphate
CN1738794B (zh) * 2002-11-22 2010-12-22 雅各布斯制药公司 双胍和二氢三嗪衍生物
US7256218B2 (en) * 2002-11-22 2007-08-14 Jacobus Pharmaceutical Company, Inc. Biguanide and dihydrotriazine derivatives
WO2006084033A1 (en) * 2005-02-03 2006-08-10 Signum Biosciences, Inc. Compositions and methods for enhancing cognitive function
US7923041B2 (en) 2005-02-03 2011-04-12 Signum Biosciences, Inc. Compositions and methods for enhancing cognitive function
EP2194985B1 (en) 2007-10-08 2019-02-20 MMV Medicines for Malaria Venture Antimalarial compounds with flexible side-chains
KR20100098602A (ko) * 2007-10-13 2010-09-08 코넬 유니버시티 마이코박테리움 아비움 아종 파라투베르쿨로시스에 대한 면역 응답을 유발하기 위한 조성물
CA2758424C (en) 2008-04-21 2018-03-06 Signum Biosciences, Inc. Tryptamine derivatives as pp2a methylation modulators
BRPI0908701A2 (pt) * 2008-05-09 2015-07-21 Tolmar Inc Composição, método para o tratamento de uma doença ou distúrbio de pelo ou mucosa, método para o tratamento de acne, método de extermínio ou inibição do crescimento de bactérias, protozoários ou fungos e uso de proguanil
US10829440B2 (en) 2015-06-12 2020-11-10 Brown University Antibacterial compounds and methods of making and using same
US11261157B2 (en) 2016-12-08 2022-03-01 Novatarg, Inc. Fused bicyclic alkylene linked imidodicarbonimidic diamides, methods for synthesis, and uses in therapy
US11555010B2 (en) 2019-07-25 2023-01-17 Brown University Diamide antimicrobial agents

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB603070A (en) * 1946-01-25 1948-06-08 Albert Frederick Crowther Manufacture of biguanide derivatives
GB665680A (en) * 1948-02-20 1952-01-30 Rhone Poulenc Sa Improvements in or relating to the production of n-p-chlorophenyl-n-isopropyl biguanide
DE824942C (de) * 1949-01-31 1951-12-17 Ici Ltd Verfahren zur Herstellung von Biguanidderivaten
GB667116A (en) * 1949-04-25 1952-02-27 Albert Frederick Crowther Manufacture of biguanide derivatives
GB814563A (en) * 1956-11-15 1959-06-10 Vitamins Ltd Biguanides
GB1270831A (en) * 1968-11-22 1972-04-19 Beecham Group Ltd Di-hydro triazine derivatives and processes for their manufacture
GB1250531A (ja) * 1969-01-01 1971-10-20
US3723429A (en) * 1969-11-06 1973-03-27 Beecham Group Ltd Di-hydro triazine derivatives
US3660394A (en) * 1970-01-23 1972-05-02 Vitamins Ltd 4 6-dibenzo-1 2-dihydro-aryloxy-1 3 5-triazines

Also Published As

Publication number Publication date
NO942988L (no) 1994-10-05
ES2108862T3 (es) 1998-01-01
HU220389B (hu) 2002-01-28
PL172001B1 (pl) 1997-07-31
AU3475993A (en) 1993-09-03
NO942988D0 (no) 1994-08-12
RU94039539A (ru) 1997-05-27
HU9401976D0 (en) 1994-09-28
DK0625967T3 (da) 1998-03-23
EP0625967A1 (en) 1994-11-30
FI943738A0 (fi) 1994-08-12
CA2129430C (en) 2004-04-06
CA2129430A1 (en) 1993-08-15
MX9300688A (es) 1993-08-01
EG20476A (en) 1999-05-31
JPH07503730A (ja) 1995-04-20
IL104484A (en) 1998-07-15
US5322858A (en) 1994-06-21
ZA93974B (en) 1993-09-14
RU2133737C1 (ru) 1999-07-27
DE69313438D1 (de) 1997-10-02
CN1076689A (zh) 1993-09-29
IL104484A0 (en) 1993-05-13
ATE157352T1 (de) 1997-09-15
KR950700243A (ko) 1995-01-16
CZ196494A3 (en) 1995-10-18
FI943738A (fi) 1994-10-12
HUT68802A (en) 1995-07-28
GR3025429T3 (en) 1998-02-27
JP3207200B2 (ja) 2001-09-10
EP0625967B1 (en) 1997-08-27
WO1993016037A1 (en) 1993-08-19
OA10094A (en) 1996-12-18
CN1057520C (zh) 2000-10-18
CZ294257B6 (cs) 2004-11-10
NZ245865A (en) 1996-02-27
AU668709B2 (en) 1996-05-16
PL173258B1 (pl) 1998-02-27
DE69313438T2 (de) 1998-03-19

Similar Documents

Publication Publication Date Title
NO942988D0 (no) N,N'-substituerte imidokarbonimid diaminer avledet fra hydroksylaminer
ES2086856T3 (es) 5'-desoxi-5-fluorocitidinas n-oxicarbonil sustituidas.
MY110821A (en) Oxidation inhibited arylcyclobutene polymers
DK0870765T3 (da) Aminothiazolderivat, lægemiddel indeholdende samme og mellemprodukt til fremstilling af forbindelsen
CA2528122A1 (en) Trans-1,2-cyclohexane bis[urea-urethane] compounds
PT1280809E (pt) Derivados antitumorais de ecteinascidina
ES8500903A1 (es) Un procedimiento para la preparacion de un derivado del indol.
WO2001010834A3 (en) Antibacterial agents
FI971227A0 (fi) Pyramidinyylipyratsolijohdannaisia
DK0548338T3 (da) Fremgangsmåde til fremstilling af cephalosporinmellemprodukter
ES2180201T3 (es) Derivados de azetidinona para el tratamiento de infecciones por hcmv.
DK0504807T3 (da) Anvendelse af bis(p-hydroxyphenylthio)methanderivater til inhibering af progressiv udvikling af insulinafhængig diabetes mellitus
FR2794122B1 (fr) Nouveaux antioxydants, procedes de preparation et utilisations

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees